← All organizations
Highest phase reached
Phase 3
Timeline
2010s
- Jun 1, 2011
Foresee Pharmaceuticals Co., Ltd.— Founded
2020s
- May 25, 2021
leuprolide— Marketing Organization
Drugs by trial phase (5 distinct, 15 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Marketed drugs (1)
Recent trials (25)
- NCT07191535OfficialPhase 2Jan 1, 2026
- NCT07191535Lead sponsorPhase 2Jan 1, 2026
- NCT06795178Lead sponsorPhase 3Jul 1, 2025
- NCT06795178OfficialPhase 3Jul 1, 2025
- NCT06795191Lead sponsorPhase 3Jun 1, 2025
- NCT06795191OfficialPhase 3Jun 1, 2025
- NCT06475781OfficialPhase 2Dec 31, 2024
- NCT06475781Lead sponsorPhase 2Dec 31, 2024
- NCT06334211Lead sponsorPhase 1Apr 16, 2024
- NCT05493709Study directorPhase 3Oct 15, 2022
- NCT05493709Lead sponsorPhase 3Oct 15, 2022
- NCT05493709OfficialPhase 3Oct 15, 2022
- NCT04750278Lead sponsorPhase 2/Phase 3Apr 6, 2021
- NCT04522375Lead sponsorPhase 1/Phase 2Dec 31, 2020
- NCT03858686Lead sponsorPhase 2Jul 2, 2018
Details
- Founded
- Taipei, TW Jun 1, 2011
- Last known activity
- Jan 1, 2026